[Gene mutations from 511 myelodysplastic syndromes patients performed by targeted gene sequencing].

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 15 citations in OpenAlex.

1. [Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
   Article
2. [Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
   Article
3. [Clinical characteristics and prognosis of myelodysplastic neoplasms with chromosome 1 abnormalities].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
   Article
4. [Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
   Article
5. [Analysis of the association between pre- and post-treatment genetic mutation status and treatment efficacy and survival in patients with newly diagnosed myelodysplastic syndromes with excess blasts receiving hypomethylating agent therapy].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025
   Article
6. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2023
   Article
7. [Risk factors for leukemia transformation in patients with myelodysplastic syndromes].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
   Article
8. [Clinical and laboratory features compared between JAK2 exon12 and JAK2 V617F mutated polycythemia vera].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
   Article
9. [Overall survival and prognosis of patients with polycythemia vera: an analysis based on 906 patients from a single center].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
   Article
10. [Comparison of genetic mutations in myelodysplastic syndrome and acute myeloid leukemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
    Article
11. [Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
12. [Molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
13. [Clinical features and prognostic analysis of myelodysplastic syndromes patients with U2AF1 mutation].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
14. [Mean corpuscular volume ≤100 fl was an independent prognostic factor in patients with myelodysplastic syndrome and bone marrow blast<5 percent].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
15. [Analysis of clinical characteristics, treatment response rate and survival of 77 myelodysplastic syndrome patients with del (5q) syndrome].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2019
    Article
16. [Clinical analysis of VAF value difference of gene mutation in myelodysplastic syndrome].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2019
    Article
17. [Clinical implications and prognostic value of TP53 gene mutation and deletion in patients with myelodysplastic syndromes].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2019
    Article
18. [High throughput sequencing combined with DNA-PCR for detection of 51 kinds of hematologic malignancy related gene mutations in patients with myelodysplastic syndromes].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

15 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as